Journal of Clinical Pharmacy and Therapeutics · 2006 · 58 citations · 11 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyEpilepsyNeuropharmacologyAcid-base DisordersAcid-base ManagementAntiepileptic PharmacologyAntiepileptic PharmacotherapySeizure ManagementAnticonvulsant PharmacologyAntiepileptic Drug InteractionsMechanisms Of Seizure ControlSeizuresValproate PharmacologyValproic Acid
A 55-year-old woman was diagnosed with pneumonia and was treated with meropenem; 5 days later she developed epileptic seizures. She had been treated with valproic acid for 16 years to control her epileptic seizures. Her serum valproic acid concentration was low during treatment with meropenem than previously recorded despite an increase of valproic dose. As soon as administration of meropenem was withdrawn, valproic acid concentration increased to previous levels and her seizures stopped. Meropenem decreases valproic acid concentration, and may promote the development of epileptic seizures in previously controlled epileptic patients. The acute lowering of serum valproate produced by meropenem probably precludes their concomitant use.
11
The pharmacokinetics of meropenem in volunteers
Richard Bax, W Bastain, A. Featherstone et al. · Journal of Antimicrobial Chemotherapy · 1989 · 160 citations
Reduction of Steady‐State Valproate Levels by Other Antiepileptic Drugs
J. Chris Sackellares, Susumu Satô, Fritz E. Dreifuss et al. · Epilepsia · 1981 · 65 citations · Full text